Page last updated: 2024-08-22

lutetium and everolimus

lutetium has been researched along with everolimus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costa, FP; de Herder, WW; Feelders, RA; Gumz, B; Kaltsas, G; Kamp, K; Kwekkeboom, DJ1
Claringbold, PG; Turner, JH1

Trials

1 trial(s) available for lutetium and everolimus

ArticleYear
NeuroEndocrine Tumor Therapy with Lutetium-177-octreotate and Everolimus (NETTLE): A Phase I Study.
    Cancer biotherapy & radiopharmaceuticals, 2015, Volume: 30, Issue:6

    Topics: Adult; Aged; Everolimus; Female; Humans; Lutetium; Male; Middle Aged; Neuroendocrine Tumors; Radionuclide Imaging; Treatment Outcome

2015

Other Studies

1 other study(ies) available for lutetium and everolimus

ArticleYear
Safety and efficacy of everolimus in gastrointestinal and pancreatic neuroendocrine tumors after (177)Lu-octreotate.
    Endocrine-related cancer, 2013, Volume: 20, Issue:6

    Topics: Adult; Aged; Bone Neoplasms; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Intestinal Neoplasms; Liver Neoplasms; Lutetium; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Prognosis; Retrospective Studies; Safety; Sirolimus; Stomach Neoplasms; Survival Rate

2013